Topic Hub
22 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 22 of 22 clinical reviews.
Clinical guide to the drug interaction between Lantus (insulin glargine) and progesterone hormone replacement therapy, including mechanism, severity, monitoring, and dose adjustment.
Read clinical reviewCan you take Lantus with testosterone? Learn about the insulin glargine and testosterone interaction, including effects on blood glucose, polycythemia risk, monitoring protocols, and dose adjustments.
Read clinical reviewA clinical review of the insulin glargine (Lantus) and acetaminophen interaction, covering pharmacodynamic effects, CGM interference, hepatic considerations, monitoring protocols, and patient counseling.
Read clinical reviewClinical guide to the insulin glargine (Lantus) and atorvastatin interaction, including mechanism, severity, monitoring parameters, and dose adjustment recommendations.
Read clinical reviewIs it safe to take insulin glargine (Lantus) with clopidogrel (Plavix)? A clinical review of the pharmacokinetic and pharmacodynamic interaction profile, monitoring recommendations, and dose-adjustment guidance.
Read clinical reviewA clinical guide to the interaction between insulin glargine (Lantus) and diphenhydramine (Benadryl), covering mechanism, severity, monitoring, and dose adjustments.
Read clinical reviewIs it safe to take insulin glargine (Lantus) with finasteride? A clinical review of pharmacokinetic and pharmacodynamic data, drug interaction database ratings, and monitoring recommendations.
Read clinical reviewA clinical guide to the interaction between insulin glargine (Lantus) and hormonal contraceptives, including mechanism, severity, monitoring, and dose adjustment.
Read clinical reviewClinical guide to the insulin glargine (Lantus) and levothyroxine interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling.
Read clinical reviewEvidence-based guide to the insulin glargine (Lantus) and metformin drug interaction, including pharmacodynamic synergy, hypoglycemia risk, dose adjustment protocols, and monitoring guidelines for type 2 diabetes.
Read clinical reviewClinical guide to the insulin glargine and NSAID drug interaction, covering hypoglycemia risk, renal effects, monitoring protocols, and dose adjustment strategies.
Read clinical reviewClinical guide to the drug interaction between insulin glargine (Lantus) and opioids including oxycodone, hydrocodone, and tramadol. Covers hypoglycemia risk, monitoring, and dose adjustment.
Read clinical reviewClinical review of the interaction between insulin glargine (Lantus) and proton pump inhibitors (omeprazole, pantoprazole), covering mechanism, severity, monitoring, and dose adjustment.
Read clinical reviewClinical guide to the insulin glargine (Lantus) and prednisone drug interaction, including mechanism, severity, dose adjustment strategies, monitoring protocols, and patient counseling.
Read clinical reviewA clinical guide to the insulin glargine (Lantus) and pregabalin interaction, covering mechanism, severity, monitoring parameters, dose adjustments, and patient counseling.
Read clinical reviewEvidence-based review of the insulin glargine (Lantus) and rivaroxaban drug interaction, including mechanism, clinical significance, monitoring parameters, and dose adjustment guidance.
Read clinical reviewCan you take Lantus (insulin glargine) with rosuvastatin? A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile, monitoring protocols, and dose-adjustment considerations.
Read clinical reviewA clinical guide to the insulin glargine (Lantus) and sildenafil drug interaction, covering mechanism, hypoglycemia risk, blood pressure monitoring, dose adjustment, and patient counseling.
Read clinical reviewA clinical guide to the insulin glargine (Lantus) and simvastatin drug interaction, covering mechanism, severity, monitoring protocols, dose adjustments, and patient counseling.
Read clinical reviewClinical guide to the insulin glargine (Lantus) and SSRI interaction. Covers hypoglycemia risk, monitoring protocols, dose adjustment, and patient counseling for sertraline and escitalopram use with basal insulin.
Read clinical reviewA clinical guide to the insulin glargine (Lantus) and tadalafil interaction, including hypoglycemia risk, blood pressure effects, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewClinical guide to the insulin glargine (Lantus) and trazodone drug interaction, including mechanism, severity, monitoring parameters, and dose adjustment recommendations.
Read clinical review